| Followers | 206 |
| Posts | 17546 |
| Boards Moderated | 3 |
| Alias Born | 03/08/2009 |
Thursday, November 04, 2021 6:28:23 AM
Recent AINMF News
- NetraMark Signs Contract With Global Biopharmaceutical Company to Analyze Phase 2 Depression Trial Data • GlobeNewswire Inc. • 03/11/2026 11:00:00 AM
- NetraMark Closes Final Tranche of $3.5 Million Private Placement • GlobeNewswire Inc. • 02/19/2026 12:00:00 PM
- Netramark Announces Uplisting to Toronto Stock Exchange • GlobeNewswire Inc. • 02/13/2026 12:00:00 PM
- NetraMark Strengthens Board Of Directors • GlobeNewswire Inc. • 01/29/2026 01:30:00 PM
- NetraMark Closes First Tranche of Private Placement • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- NetraMark Engages LodeRock Advisors for Strategic Investor Relations and Capital Markets Communications Services • GlobeNewswire Inc. • 01/22/2026 01:30:00 PM
- NetraMark Announces Private Placement Financing • GlobeNewswire Inc. • 01/13/2026 01:30:00 PM
- NetraMark Delivers Transformational Quarter Of Execution • GlobeNewswire Inc. • 12/18/2025 01:30:00 PM
- NetraMark and CAMH Announce Research Award to Advance AI-Driven Discovery in Schizophrenia and Depression • GlobeNewswire Inc. • 12/16/2025 01:30:00 PM
- NetraMark Continues Expansion Into Phase 3 Programs With Contract From Global Biopharmaceutical Company • GlobeNewswire Inc. • 12/11/2025 01:30:00 PM
- NetraAI Study Accepted for Publication in npj Digital Medicine, Part of the Nature Portfolio • GlobeNewswire Inc. • 12/08/2025 01:30:00 PM
- NetraMark Signs Four New Contracts With a Leading Global Pharmaceutical Company To Enhance Clinical Trial Insights • GlobeNewswire Inc. • 11/18/2025 01:30:00 PM
- Netramark Signs Contract with a Leading Global Biopharmaceutical Company to Enhance Clinical Trial Insights • GlobeNewswire Inc. • 11/03/2025 01:30:00 PM
- NetraMark Presents AI-Driven Advances in Precision Psychiatry to Enhance Clinical Trial Designs at Joint Autumn Conference • GlobeNewswire Inc. • 10/29/2025 10:30:00 AM
- NetraMark Initiates AI-Driven Collaboration in Glioblastoma Research • GlobeNewswire Inc. • 09/22/2025 12:30:00 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
